Literature DB >> 11160158

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

R Kaul1, S L Rowland-Jones, J Kimani, T Dong, H B Yang, P Kiama, T Rostron, E Njagi, J J Bwayo, K S MacDonald, A J McMichael, F A Plummer.   

Abstract

Resistance to HIV infection in a small group of Kenyan sex workers is associated with CD8+-lymphocyte responses to HIV cytotoxic T-lymphocyte (CTL) epitopes. Eleven prostitutes meeting criteria for HIV resistance seroconverted between 1996 and 1999. The occurrence and specificity of preexisting HIV-1 epitope-specific responses were examined using the IFN-gamma enzyme-linked immunospot assay, and any epitopes recognized were cloned and sequenced from the infecting viral isolate. Immunologic and behavioral variables were compared between late seroconverters and persistently uninfected sex worker controls. HIV-1 CTL epitope responses were present in four of six cases, 5-18 months before seroconversion, and their presence was confirmed by bulk CTL culture. A possible viral escape mutation was found in one of six epitopes. The key epidemiologic correlate of late seroconversion was a reduction in sex work over the preceding year. In persistently uninfected controls, a break from sex work was associated with a loss of HIV-specific CD8+ responses. Late seroconversion may occur in HIV-1-resistant sex workers despite preceding HIV-specific CD8+ responses. Seroconversion generally occurs in the absence of detectable CTL escape mutations and may relate to the waning of HIV-specific CD8+ responses due to reduced antigenic exposure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160158      PMCID: PMC199193          DOI: 10.1172/JCI10714

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  On the role of antigen in maintaining cytotoxic T-cell memory.

Authors:  T M Kündig; M F Bachmann; S Oehen; U W Hoffmann; J J Simard; C P Kalberer; H Pircher; P S Ohashi; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

2.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

Review 3.  Escape of human immunodeficiency virus from immune control.

Authors:  A J McMichael; R E Phillips
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

4.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.

Authors:  D A Price; P J Goulder; P Klenerman; A K Sewell; P J Easterbrook; M Troop; C R Bangham; R E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

6.  Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.

Authors:  L Mortara; F Letourneur; H Gras-Masse; A Venet; J G Guillet; I Bourgault-Villada
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Correlates of protection in HIV infection and the progression of HIV infection to AIDS.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Lett       Date:  1996-06       Impact factor: 3.685

9.  Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy.

Authors:  M Dalod; M Harzic; I Pellegrin; B Dumon; B Hoen; D Sereni; J C Deschemin; J P Levy; A Venet; E Gomard
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

Review 10.  Progress in the development of an HIV-1 vaccine.

Authors:  N L Letvin
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

View more
  67 in total

1.  Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.

Authors:  Itaru Anraku; Tracey J Harvey; Richard Linedale; Joy Gardner; David Harrich; Andreas Suhrbier; Alexander A Khromykh
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  HIV versus the immune system: another apparent victory for the virus.

Authors:  N L Letvin; B D Walker
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Authors:  Jeffrey D Lifson; Nancy L Haigwood
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

4.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

5.  Out of the armchair: a bioethics student's search for practical knowledge in Kenya.

Authors:  Nicole Li
Journal:  J Bioeth Inq       Date:  2004       Impact factor: 1.352

Review 6.  Resistance to HIV infection.

Authors:  M Marmor; K Hertzmark; S M Thomas; P N Halkitis; M Vogler
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

Review 7.  The molecular mechanism of human resistance to HIV-1 infection in persistently infected individuals--a review, hypothesis and implications.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

8.  Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus.

Authors:  Rob J De Boer
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

9.  Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Authors:  John R Mascola; Mark G Lewis; Thomas C VanCott; Gabriela Stiegler; Hermann Katinger; Michael Seaman; Kristin Beaudry; Dan H Barouch; Birgit Korioth-Schmitz; Georgia Krivulka; Anna Sambor; Brent Welcher; Daniel C Douek; David C Montefiori; John W Shiver; Pascal Poignard; Dennis R Burton; Norman L Letvin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Authors:  Suresh Pallikkuth; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  Clin Vaccine Immunol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.